Rivera Jose E

CIK 00016718701 companyCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001671870

Recent Transactions

50 trades

Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-04-01$81.89/sh−8,266→ 138,566 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2021-04-01−33,001→ 6,116 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-04-01$81.95/sh−2,644→ 147,199 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-04-01$82.87/sh−951→ 146,248 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-04-01$85.14/sh−123→ 145,076 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-04-01$81.87/sh−6,768→ 169,344 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-04-01$82.77/sh−3,361→ 165,983 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-04-01$84.73/sh−1,213→ 162,512 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2021-04-01−10,000→ 51,000 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-04-01$80.79/sh−2,010→ 146,832 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-04-01$82.63/sh−2,728→ 143,230 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-04-01$83.85/sh−2,258→ 163,725 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2021-04-01−33,000→ 39,000 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-04-01$82.76/sh−3,233→ 135,333 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-04-01$84.94/sh−1,067→ 131,032 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-04-01$18.30/sh+21,000→ 152,032 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-04-01$80.82/sh−1,256→ 150,776 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-04-01$84.87/sh−963→ 140,543 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-04-01$83.91/sh−3,234→ 132,099 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-04-01$81.83/sh−4,818→ 145,958 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-04-01$83.72/sh−1,724→ 141,506 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-04-01$13.88/sh+33,000→ 148,842 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-04-01$14.58/sh+10,000→ 150,543 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-04-01$80.73/sh−700→ 149,843 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-04-01$83.98/sh−1,049→ 145,199 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-04-01$6.83/sh+33,001→ 178,077 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-04-01$80.85/sh−1,965→ 176,112 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-04-01$85.76/sh−124→ 162,388 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2021-04-01−21,000→ 29,090 total
Award
Intellia Therapeutics, Inc.$NTLA
Restricted Stock Unit
2021-03-03+12,250→ 12,250 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2021-03-03+73,500→ 73,500 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-02-09$18.30/sh+21,000→ 129,409 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-02-09$75.00/sh−11,489→ 117,920 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2021-02-09−21,000→ 50,090 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-02-01$13.88/sh+33,000→ 121,686 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-02-01$63.34/sh−6,617→ 115,069 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2021-02-01−10,000→ 61,000 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-02-01$65.07/sh−755→ 108,409 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-02-01$64.16/sh−8,366→ 106,703 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-02-01$65.01/sh−5,312→ 88,686 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-02-01$64.18/sh−2,386→ 109,164 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2021-02-01−66,000→ 39,117 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-02-01$63.31/sh−10,476→ 109,592 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-02-01$64.11/sh−15,594→ 93,998 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2021-02-01−33,000→ 72,000 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-02-01$65.05/sh−2,827→ 103,876 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-02-01$14.58/sh+10,000→ 113,876 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-02-01$63.44/sh−2,326→ 111,550 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-02-01$6.83/sh+66,000→ 120,068 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-01-05$55.86/sh−2,078→ 51,990 total

Companies

Intellia Therapeutics, Inc.
Chief Operating & Legal Offr, 10% Owner
$NTLA

Recent Filings

4
Rivera Jose E
Apr 2, 2021

Address

C/O INTELLIA THERAPEUTICS, INC. 130 BROOKLINE STREET, SUITE 201

CAMBRIDGE, MA, 02139

View on SEC.gov